IL1B and pemphigus foliaceus: In both in vivo and in vitro models of bleomycin-induced PF, scutellarin treatment dose-dependently suppressed NF-κB activation and canonical NLRP3 inflammasome components, reducing downstream IL-1β and IL-18 production [98].